Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.78 HKD | -2.20% | +1.71% | -21.24% |
Mar. 20 | JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023 | MT |
Mar. 20 | JW Therapeutics Co. Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar JW (Cayman) Therapeutics Co. Ltd
Upcoming events on JW (Cayman) Therapeutics Co. Ltd
Past events on JW (Cayman) Therapeutics Co. Ltd
2024-03-20 08:30 pm | Q4 2023 Earnings Call |
2024-03-19 | Q4 2023 Earnings Release |
2023-08-28 | Q2 2023 Earnings Release |
2023-03-28 | Q4 2022 Earnings Release |
2022-12-01 08:00 pm | Extraordinary Shareholders Meeting |
2022-08-29 | Interim 2022 Earnings Release |
2022-06-28 09:00 pm | Annual General Meeting |
2022-06-04 09:00 am | American Society of Clinical Oncology Meeting - Abstract number: 7529 |
2022-06-03 | American Society of Clinical Oncology Meeting - Abstract number: e19509 |
2022-03-22 | FY 2021 Earnings Release |
2021-12-09 | American Society of Hematology Meeting - Abstract No: #2434 |
2021-08-26 | Interim 2021 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 0,00 | 0,00 0,00 - | 30,8 70,9 -56.54% | 146 159 -8.59% | 174 196 -11.44% |
EBITDA Million CNY | Released Forecast Spread | 0,00 | -417 -253 -64.82% | -738 -503 -46.67% | -635 -714 11.09% | -481 -588 18.24% |
EBIT Million CNY | Released Forecast Spread | 0,00 | -441 -313 -40.83% | -778 -578 -34.43% | -720 -793 9.19% | -579 -627 7.69% |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 | -1 664 -1 247 -33.42% | -702 -592 -18.55% | -846 -868 2.53% | -768 -681 -12.71% |
Net income Million CNY | Released Forecast Spread | -633 | -1 664 -1 247 -33.42% | -702 -592 -18.55% | -846 -868 2.53% | -768 -681 -12.71% |
EPS CNY | Released Forecast Spread | -9,74 | -12,6 -2,84 -344.72% | -1,76 -1,38 -27.25% | -2,06 -2,13 3.17% | -1,87 -1,66 -12.79% |
Announcement Date | 21/10/20 | 26/03/21 | 23/03/22 | 29/03/23 | 20/03/24 |
Quarterly results
Fiscal Period | December | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 30,8 67,0 -54.05% | 66,0 58,9 12.14% | 79,7 81,1 -1.79% | 87,7 164 -46.54% | 86,1 96,5 -10.77% | 108 | 132 |
EBIT Million CNY | Released Forecast Spread | -337 -285 -18.17% | -441 -270 -63.28% | -348 -464 24.89% | -372 -403 7.86% | -311 -363 14.41% | -268 -288 6.8% | -273 | -280 | |
EPS CNY | Released Forecast Spread | -0,71 -0,70 -1.43% | -1,05 -0,67 -56.72% | -1,05 -1,14 7.89% | -1,01 -1,00 -1% | -0,93 -0,85 -9.41% | -0,94 -0,81 -16.05% | -0,64 | -0,66 | |
Announcement Date | 26/03/21 | 27/08/21 | 23/03/22 | 30/08/22 | 29/03/23 | 29/08/23 | 20/03/24 | - | - |
Today 04:05 pm | EXELIXIS, INC.: Q1 2024 Earnings Release |
2024-04-30 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
2024-04-30 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-01 07:00 am | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-01 04:05 pm | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-01 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-01 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
2024-05-01 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for JW (Cayman) Therapeutics Co. Ltd
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 2126 Stock
- Calendar JW (Cayman) Therapeutics Co. Ltd